Published in J Appl Physiol (1985) on December 01, 1990
Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care (2005) 1.51
Skeletal muscle pump versus respiratory muscle pump: modulation of venous return from the locomotor limb in humans. J Physiol (2005) 1.07
Influence of support on intra-abdominal pressure, hepatic kinetics of indocyanine green and extravascular lung water during prone positioning in patients with ARDS: a randomized crossover study. Crit Care (2005) 0.96
The arterial baroreflex resets with orthostasis. Front Physiol (2012) 0.95
The abdominal circulatory pump. PLoS One (2009) 0.94
Commonly applied positive end-expiratory pressures do not prevent functional residual capacity decline in the setting of intra-abdominal hypertension: a pig model. Crit Care (2010) 0.88
Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome. Hypertension (2014) 0.84
Perioperative intravascular fluid assessment and monitoring: a narrative review of established and emerging techniques. Anesthesiol Res Pract (2011) 0.81
Effects of norepinephrine on tissue perfusion in a sheep model of intra-abdominal hypertension. Intensive Care Med Exp (2015) 0.80
Expiratory loading improves cardiac output during exercise in heart failure. Med Sci Sports Exerc (2012) 0.79
Advanced pressure control modes of ventilation in cardiac surgery: Scanty evidence or unexplored terrain? Indian J Crit Care Med (2016) 0.75
Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction. Am J Physiol Heart Circ Physiol (2016) 0.75
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Effects of respiration on cardiac performance. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.55
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Do low-dose inhalational anesthetic agents alter ventilatory control? Anesthesiology (1994) 1.39
Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol (1977) 1.38
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther (1993) 1.38
Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) (1995) 1.36
Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci (1994) 1.35
Catecholamine theories of reward: a critical review. Brain Res (1978) 1.35
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav (1982) 1.34
Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science (1976) 1.34
Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med (1998) 1.33
Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis: treatment with high-concentration oxygen. Chest (2000) 1.33
The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med (2001) 1.29
Tracheal and neck position influence upper airway airflow dynamics by altering airway length. J Appl Physiol (1985) (1993) 1.28
Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study. Brain Res (1980) 1.28
Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr (1984) 1.27
Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse (1999) 1.26
Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav (1989) 1.26
Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. J Neurosci (1999) 1.26
Mechanism of decreased left ventricular stroke volume during inspiration in man. Circulation (1984) 1.25
Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur J Neurosci (2001) 1.25
Incidence of lung cancer in systemic sclerosis. J Rheumatol (1985) 1.22
Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci (1998) 1.21
Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis (1993) 1.18
The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol (2001) 1.16
Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav (1991) 1.15
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest (1998) 1.14
Acute iron poisoning. A review. Am J Dis Child (1980) 1.14
Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience (2001) 1.13
Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13
Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr Res (1987) 1.11
Heroin reward is dependent on a dopaminergic substrate. Life Sci (1981) 1.10
Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol (1985) (1989) 1.10
Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) (1996) 1.09
Impact of guinea worm disease on children in Nigeria. Am J Trop Med Hyg (1986) 1.08
Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am J Physiol (1993) 1.05
Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res (1976) 1.04
Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci (2001) 1.04
Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science (1984) 1.03
The acute-phase response. New Horiz (1995) 1.03
Reflex modulation of airflow dynamics through the upper airway. J Appl Physiol (1985) (1994) 1.02
Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci (1998) 1.01
A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol (1982) 1.01
Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. J Appl Physiol (1985) (2000) 1.01
Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav (1989) 1.01
Treatment of capsulitis of the shoulder. Rheumatol Rehabil (1975) 1.01
Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci (1994) 1.01
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Relationship between blood pressure and airway obstruction during sleep in the dog. J Appl Physiol (1985) (1994) 1.00
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) (1984) 1.00
Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure. J Appl Physiol (1985) (1988) 0.99
Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.99
Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res Bull (1984) 0.98
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med (1984) 0.97
Negative intrathoracic pressure decreases independently left ventricular filling and emptying. Am J Physiol (1989) 0.97
Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit Care Med (1996) 0.96
Effect of lung inflation on lung blood volume and pulmonary venous flow. J Appl Physiol (1985) (1985) 0.96
Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav (1980) 0.96
Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res (1999) 0.96
Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can J Psychol (1978) 0.96
Quality assessment through patient self-report of symptoms prefiberoptic and postfiberoptic bronchoscopy. Chest (1998) 0.95
Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med (1995) 0.95
Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol (1997) 0.95
Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther (1994) 0.93
The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Chest (1982) 0.93
Assessment of occupational exposure to organophosphates in pest control operators. Am Ind Hyg Assoc J (1980) 0.93
A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol (1982) 0.93
Transient analysis of cardiopulmonary interactions. I. Diastolic events. J Appl Physiol (1985) (1988) 0.93